Related Articles
Crafting a Clinical Trials Hub
Clinical trials have the power to improve patient outcomes and save lives. Cedars-Sinai is at the forefront of innovation and expansion.
Updates in immunotherapy for skin cancer
In this podcast, we highlight some of the latest updates in the use of immunotherapy to treat skin cancer. This…
Personalized Cancer Vaccines Directed against Tumor Mutations: Building Evidence from Mice to Humans
Abstract. Personalized vaccines directed to tumor mutations have recently gained significant momentum. On the basis of the concept of stimulating T-cell responses against neoantigens encoded…
2024 Melanoma Updates – Justin T. Moyers, MD – MOASC 2024
Justin T. Moyers, MD – Medical Oncology – The Angeles Clinic and Research Institute provides an overview of recent updates in melanoma treatment, including long-term…
Melanoma Bridge – Immunotherapy Bridge
It is our pleasure to announce we are now organizing Melanoma and Immunotherapy Bridge 2023, on behalf of Fondazione Melanoma Onlus. Upcoming annual appointments for…
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients
Pembrolizumab has a manageable safety profile as described in its label, which was primarily based on 2799 patients who participated in clinical trial…
Cancer Care Centers West Los Angeles and Santa Monica | The Angeles Clinic and Research Institute
The Angeles Clinic & Research Institute has established an international reputation for developing new cancer therapies.